74PPhase I expansion cohort results of cemiplimab, a human PD-1 monoclonal antibody, in combination with radiotherapy (RT), cyclophosphamide and GM-CSF, in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC)
Babiker, H M, Brana, I, Mahadevan, D, Owonikoko, T K, Calvo, E, Rischin, D, Moreno, V, Papadopoulos, K P, Crittenden, M, Formenti, S, Giralt, J, Garrido, P, Hervás Morón, A, Mohan, K K, Fury, M G, LowVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy487.005
Date:
December, 2018
File:
PDF, 80 KB
2018